Finance

Beta
Ask
Lists
CARM:OTCMKTS
Carisma Therapeutics Inc
$0.0061
+7.02%
(+0.00040) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CARM...
Open
$0.01
High
$0.01
Low
$0.01
Mkt. cap
145.50K
Avg. vol.
44.04K
Volume
6.54K
P/E ratio
0.03
52-wk high
$0.70
52-wk low
$0.00
EPS
$0.19
Beta
1.87
Shares outstanding
41.84M
No. of employees
46
Open
$0.01
High
$0.01
Low
$0.01
Mkt. cap
145.50K
Avg. vol.
44.04K
Volume
6.54K
P/E ratio
0.03
52-wk high
$0.70
52-wk low
$0.00
EPS
$0.19
Beta
1.87
Shares outstanding
41.84M
No. of employees
46
News stories
From sources across the web
About Carisma Therapeutics Inc
CEO-
Employees46
Founded2008
HeadquartersPhiladelphia, Pennsylvania, United States
SectorBiotechnology
Websitecarismatx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
3.65M
3.73M
-
45.25M
Cost of goods sold
15.58M
9.16M
2.42M
197.00K
Cost of revenue
15.58M
9.16M
2.42M
197.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.93M
3.91M
3.35M
1.24M
Operating expense
3.93M
3.91M
3.35M
1.24M
Total operating expenses
19.51M
13.06M
5.78M
1.44M
Operating income
-15.86M
-9.33M
-5.78M
43.81M
Other non operating income
-
-
470.00K
-17.00K
EBT including unusual items
-17.64M
-9.27M
-9.77M
44.72M
EBT excluding unusual items
-15.64M
-9.27M
-5.31M
44.40M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.64M
-9.27M
-9.77M
44.72M
Net profit margin
-482.75%
-248.48%
-
98.82%
Earnings per share
-0.42
-0.22
-0.13
-
Interest and investment income
220.00K
100.00K
-
600.00K
Interest expense
-
-32.00K
-
-
Net interest expenses
220.00K
68.00K
-
600.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.19M
-8.67M
-5.78M
43.81M
Gain or loss from assets sale
49.00K
-113.00K
3.54M
-320.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer